Endocrine Flashcards
(74 cards)
1
Q
examples of lipid-soluble hormones
A
- steroids
- thyroid hormones
2
Q
examples of water-soluble hormones
A
- peptides
- proteins
3
Q
Lipid-soluble Hormones
- receptor location
- intracellular action
- storage
- plasma transport
- half-life
A
- inside the cell (usually nucleus)
- stimulated synthesis of specific new proteins
- synthesized as needed (exception = thyroid hormones)
- attached to proteins (made by liver) that serve as carriers for plasma transport (exception: adrenal androgens)
- ex) cortisol-binding globulin; thyroid-binding globulin; sex hormone-binding globulin (SHBG)
- the lipid-soluble hormone circulating in plasma (bound to protein) is in equilibrium with a small amount of free hormone (total hormone = bound + free)
- it is the FREE hormone that is available to tissues and normally determines the plasma activity
- half-life: long (hours/days); proportional to the affinity for the protein carrier
4
Q
Water-soluble Hormones
- receptor location
- intracellular action
- storage
- plasma transport
- half-life
A
- outer surface of cell membrane
- production of 2nd messangers (i.e. cAMP)
- 2nd messengers modify action of intracellular proteins )(enzymes)
- insulin does not utilize cAMP, instead activates membrane-bound tyrosine kinase
- stored in vesicles
- in some cases, pro hormone stored in vesicle along w an enzyme that splits off the active hormone, releasing inactive peptide
- dissolved in plamsa (free, unbound) for plasma transport
- short half-life (minutes); proportional to molecular weight
5
Q
Effect of estrogen on the circulating levels of binding protein
A
- a rise in circulating estrogen causes the release of more binding protein by the liver
- which binds more free hormone
- the transient decrease in free hormone reduces negative feedback to the hormone-secreting tissue
- the increased secretion of free someone quickly returns the free plasma hormone to normal.
- this is why during pregnancy and other states w a rise in estrogen levels :
1. total plasma lipid-soluble hormone increases
2. free plasma hormone remains constant at a normal level; thus the individual does not show signs of hyperfunctionm
6
Q
failure of glucose to suppress growth hormone is diagnostic for
A
acromegaly
7
Q
failure of (low dose) dextromethasone to suppress cortisol is diagnostic for
A
hypercortisolism
8
Q
TRH
A
= thyrotropin-releasing hormone
- water-soluble hormone
- released by the hypothalamus
1. targets thyrotrophs in pituitary - causes secretion of TSH
2. when TRH is elevated: - targets lactotrophs in pituitary
- causes secretion of Prolactin
9
Q
CRH
A
= corticotropin-releasing hormone
- water-soluble hormone
- released by the hypothalamus
- targets corticotrophins in pituitary
- causes secretion of ACTH
10
Q
GnRH
A
= Gonadotropin-releasing hormone
- water-soluble hormone
- released by the hypothalamus
- targets gonadotrophs in pituitary
- causes secretion of LH (high-frequency pulses), FSH (low-frequency pulses)
11
Q
GHRH
A
= growth hormone-releasing hormone
- water-soluble hormone
- released by the hypothalamus
- targets somatotrophs in pituitary
- causes secretion of GH
- GHRH is the main controlling factor for GH secretion
12
Q
PIF
A
= prolactin-inhibiting factor, aka dopamine
- water-soluble hormone
- released by the hypothalamus
- targets lactotrophs in pituitary
- INHIBITS secretion of Prolactin
13
Q
Somatostatin
A
- released by the hypothalamus
- water-soluble hormone
- targets somatotrophs in pituitary
- INHIBITS secretion of GH
14
Q
Characteristic sequential loss of function in hypopituitarism
A
- GH and gonadotropin, followed by
- TSH, then
- ACTH, and finally
- prolactin
- deficiencies in ACTH, TSH and prolactin are extremely rare. Usually a sign of panhypopituitarism
15
Q
MCC of hypopituitarism
A
- head trauma, other causes include:
- mass effects of tumors
- inflammation
- vascular damage
16
Q
isolated deficiency in gonadotropins
A
- Kallman syndrome
- tertiary defective GnRH synthesis
- decreased: LH, FSH, sex steroids
17
Q
MC tumor affecting the hypothalamic-pituitary system in children
A
- craniopharyngioma
- pituitary adenomas are rare
18
Q
Pituitary Adenomas
A
- MCC of hypothalamic-pituitary dysfunction
- microadenomas (less than 1cm in diameter): characterized by hormonal excess, no panhypopituitarism, treatable (i.e. ACTH causing Cushing’s Disease)
- Macroadenomas (more than 1cm in diameter): mass effect, larger tumors w suprasellar extension, associated with panhypopituitarism and visual loss
- hypogonadism = MCC manifestation
- uslally benign and can autonomously secrete hormone leading to hyperprolactinemia (60%), acromegaly (GH 20%) and Cushing disease (ACTH 10%)
- prolactinomas assoc w hypogonadism and galactorrhea
- MEN1 assoc
19
Q
- Hypothalamic hormones affecting the pituitary are synthesized in the
- but are stored and released from
A
- ventromedial, arcuate and preoptic nuclei
2. the median eminence
20
Q
Pulsatile system and the pulsatile release of GnRH…
A
prevents down regulation of gonadotroph receptors
21
Q
- Ant Pit hormones are regulated primarily by ____
2. except ___
A
- hypothalamic releasing hormones
2. except prolactin, which is mainly under the influence of PIF (an inhibiting hormone)
22
Q
Damage to the pituitary stalk causes a decrease in
A
- all ANT pituitary hormones
- except prolactin (which increases)
23
Q
acromegaly is associated w excess secretion of
A
GH (20%)
24
Q
Cushing syndrome is associated w excess secretion of
A
ACTH (10%)
25
MCC of anterior pituitary dysfunction
pituitary adenomas
26
1. MC tumor of anterior pituitary
| 2. MC manifestation
1. prolactinomas
| 2. hypogonadism
27
How do you evaluate hormonal hyperfunction
- a suppression test
| - a stimulation test is used to evaluate hormonal hypofunction
28
lack of glandular stimulation causes
a reversible atrophy
29
overstimulation of a gland can cause
hypertrophy or hyperplasia
30
The posterior pituitary secretes
1. Arginine vasopression (ADH) = major controller of H20 excretion and ECF volume (also controls osmolality)
2. oxytocin
- both are peptide hormones
31
The hormonal release by the hypothalamic- anterior-pituitary system is
mostly pulsatile
| - possible exception = thyroid system
32
Sheehan syndrome
- in pregnancy, pituitary is enlarged and thus more vulnerable to infection
- if delivery assoc w severe blood loss, the ensuing shock causes arteriolar spasm in the pituitary w subsequent ischemic necrosis
- failure to resume normal menstrual cycle after weaning = strong sign of potential pituitary damage
33
Cell bodies for the posterior pituitary located in the
suporaoptic nucleus and paraventricular nucleus of the hypothalamus
34
The osmoreceptor neurons in the hypothalamus are extremely sensitive and are able to maintain ECF osmolarity within a very narrow range.
- there is a resting of the osmostat downward in
- pregnancy, the menstrual cycle and w volume depletion*
| * = osmoregulation 2ndary to volume regulation; return of circulating volume occurs even though osmolarity decreases
35
____ receptors are less sensitive than _____
Volume receptors are less sensitive than osmoreceptors
| - a change of 10-15% in volume = required to produce a measurable change in ADH
36
_______ restrains the release of ADH
Cortisol and Thyroid Hormone
37
ADH is:
1. synthesized in the
2. released from the
1. synthesized in the hypothalamus
| 2. stored and released from the posterior pituitary
38
Major action of ADH
= passive reabsorption of water and urea (but not electrolytes) in the renal collecting duct
39
osmoreceptors
= very sensitive and normally maintain osmolarity in a very narrow range
40
Reduced input from the low-pressure stretch receptors is a strong stimulus for
the release of ADH
41
ADH levels in:
- Central DI
- nephrogenic DI
- Central = low plasma ADH
- nephrogenic = high plasma ADH
* easily separated by measuring plasma ADH or injection of desmopressin
* * D/D following water deprivation
42
SIADH
- inappropriate elevated secretion of ADH
- characterized by euvolemia and hyponatremia*
* acute hyponatremia = life threatening if severe; treat aggressively
43
Acute hyponatremia vs Chronic hyponatremia
1. acute hyponatremia = life threatening if severe; treat aggressively
2. Chronic hyponatremia: usually well-tolerated.
- Aggressive treatment is assoc w central pontine myelinosis
44
Permeability of collecting ducts to H2O in:
1. DI
2. Dehydration
3. SIADH
4. Primary Polydipsia
Permeability of collecting ducts to H2O in:
1. DI: decreases
2. Dehydration: increases
3. SIADH: increases
4. Primary Polydipsia: decreases
45
Urine Flow in:
1. DI
2. Dehydration
3. SIADH
4. Primary Polydipsia
Urine Flow in:
1. DI: increases
2. Dehydration: decreases
3. SIADH: decreases
4. Primary Polydipsia: increases
46
Urine osmolarity in:
1. DI
2. Dehydration
3. SIADH
4. Primary Polydipsia
Urine osmolarity in:
1. DI: decreases
2. Dehydration: increases
3. SIADH: increases
4. Primary Polydipsia: decreases
47
ECF volume in:
1. DI
2. Dehydration
3. SIADH
4. Primary Polydipsia
ECF volume in:
1. DI: decreased
2. Dehydration: decreased
3. SIADH: increased
4. Primary Polydipsia: increased
48
ECF osmolarity* (Na concentration) in:
1. DI
2. Dehydration
3. SIADH
4. Primary Polydipsia
ECF osmolarity* (Na concentration) in:
1. DI: increased
2. Dehydration: increased
3. SIADH: decreased
4. Primary Polydipsia: decreased
49
ICF volume in:
1. DI
2. Dehydration
3. SIADH
4. Primary Polydipsia
ICF volume in:
1. DI: decreased
2. Dehydration: decreased
3. SIADH: increased
4. Primary Polydipsia: increased
50
ICF osmolarity in:
1. DI
2. Dehydration
3. SIADH
4. Primary Polydipsia
ICF osmolarity in:
1. DI: increased
2. Dehydration: increased
3. SIADH: decreased
4. Primary Polydipsia: decreased
51
hypervolemia cause
- caused by marked reduction in water retention and/or increased rate of water ingestion
- ie CHF, cirrhosis
52
hypovolemia
- indicates sodium depletion
- ie mineralcorticoid deficiency,
- diuretic abuse
- renal disease
- diarrhea
- hemorrhage
53
clinical euvolemia
ie SIADH
| - clinically equivalent presentation may occur in glucocorticoid deficiency
54
Hyponatremia
- one of the MC disorders of fluid and electrolyte balance in hospitalized pts
1. involves?
- usually = to a hypo-osmolar state (exception = hyperglycemia)
- involves both solute depletion and water retention
- but water retention is usually the more important factor
2. Solute depletion can occur from any significant loss of ECF fluid
- the hyponatremia = result of replacement by more hypotonic fluids
- when develops rapidly (less than 48h) and is severe (Na less than 120) pt is at risk for seizures and respiratory arrest
- often treated aggressively with hypertonic saline and diuretics or ADH antagonists
55
Rapidly developing Hyponatremia (develops in less than 48h) that is severe (Na less than 120)
- pt is at risk for seizures and respiratory arrest
- often treated aggressively with hypertonic saline and diuretics or ADH antagonists
- aggressive treatment may result in Central Pontine Myelinolysis
- General recommendation: slowly raise [Na] over a period of days
- (more slowly developing hyponatremia appears to be well-tolerated and pt is asymptomatic)
56
SIADH treatment
- fluid restriction but not salt restriction
- Na+ disorders cause neurological symptoms
- only mild hyponatremia from SIADH can be managed w fluid restriction
- severe disease needs 3% hypertonic saline or V2 receptor antagonists
- Conivaptan and tolvaptan are V2 receptor antagonists
- they stop ADH effect on kidney tubule
57
circulating levels of brain natriuretic peptide (BNP) correlated well w
- the degree of heart failure
- although very little BNP is synthesized and released in the normal heart, there is a marked elevation as the ventricle dilates (hence the correlation)
58
Synthesis and release of ADH
- synthesized in the supraoptic (SO) and paraventricular (PVN) nuclei of the hypothalamus
- it is stored and released from the posterior pituitary
- osmoreceptors synapse w neurons of the SO and PVN and stimulate them to secrete ADH from the posterior pituitary.
- also stimulate consumption of H20 through the hypothalamic centers that regulate thirst
- the SO and PVN also receive input from cardiopulmonary mechanoreceptors as well as arterial baroreceptors.
- high blood volume or BP tends to inhibit the secretion of ADH
59
Secretion of ADH is most sensitive to
- plasma osmolarity (1%), however,
- if blood volume decreases by 10% (i.e. hemorrhage)
- or CO falls,
- high levels of ADH are secreted (even if it causes abnormal plasma osmolarity)
60
Osmoreceptors
- neurons that respond to increased plasma osmolarity (principally increased [Na+]
- synapse w neurons of the SO and PVN and stimulate them to secrete ADH from the posterior pituitary.
- also stimulate consumption of H20 through the hypothalamic centers that regulate thirst
61
Ex of V2 receptor antagonists
- Conivaptan and tolvaptan
| - used to treat SIADH
62
Action of ADH
- main target tissue = renal collecting duct (V2 receptors)
- ADH increases the permeability of the duct to water by placing water channels in the luminal membrane
- H20 reabsorbed passively, drawn across the membranes by the higher osmolarity of the interstitium
- urea can pass with the water, but electrolytes cannot
- ADH stimulates the urea transporter, increasing urea reabsorption
- in severe hemorrhage, high levels of ADH (via V1 receptors on vascular SM) cause vasoconstriction
63
Volume regulation via ADH
1. stimuli arising from stretch receptors act to chronically inhibit ADH secretion
2. decreases in blood vol cause venous and arterial stretch receptors to send fewer signals to the CNS
3. decreasing chronic inhibition of ADH secretion
- this mechanism = esp important for restoring ECF volume following hemorrhage.
64
Osmoregulation
- an increase of only 1% in the osmolality of the ECF bathing the hypothalamic osmoreceptors will evoke an increased rate of ADH secretion
- similarly sized decreased in osmolality will decrease ADH secretion
- ECF osmolality is kept very close to 285 most/Kg
65
Ingesting ethyl alcohol or being in a weightless environment ____ ADH secretion
- suppresses ADH secretion
- in weightlessness, there is a net shift of blood from the limbs to the abdomen and chest.
- this results in greater stretch of the volume receptors in the large veins and atria
- thus suppressing ADH secretion
66
ANP (ANF)
| 1. stimuli for release
- secreted by heart; found mainly in R atrium
1. stretch (independent of nervous system)
2. increased salt intake
3. CHF and all fluid overload states
- ANP (ANF) increases Na loss (natriuresis) and water loss by the kidney
- also
67
ANP (ANF) increases Na loss (natriuresis) and water loss by the kidney because of
- an increase in glomerular filtration rate due to:
1. ANP-mediated dilation of the afferent arteriole
2. ANP-mediated constriction of the efferent arteriole
- also increases Na loss and water loss (diuresis) by the kidney bc it inhibits
1. inhibits aldosterole release as well as
2. inhibits the reabsorption of Na and H20 in the collecting duct
- ANP tends to antagonize the effects of ATII and ADH
68
normal ANP level is used to exclude
CHF as a cause of dyspnea
69
Central DI
- CDI = ADH deficiency; not enough ADH available to affect the renal collecting ducts
- Tx: replacing ADH as vasopressin or DDVAP (desmopressin)
- causes: familial, tumors (craniopharyngioma) autoimmune, trauma
1. pituitary trauma --- transient DI
2. Sectioning of Pituitary stalk --- triphasic response: DI, followed by SIADH, followed by a return of DI
3. destruction of the hypothalamus from any cause can lead to DI.
- ex) stroke, hypoxia, head trauma, infection, cancer, mass lesion
70
SIADH
- excessive secretion of ADH causes inappropriate increased reabsorption of water in the renal collecting duct
- SIADH = any urine Osm greater than 100 w hyponatremia
- w Hyponatremia, a normal person should have urine Na and Osmolarity that are low
- in SIADH, it's a disease bc urine Na and osmolarity are inappropriately high
71
Nephrogenic DI
- due to inability of kidneys to respond to ADH
- causes: familial, acquired, drugs (lithium)
- hypokalemia
- hypercalcemia
72
Causes of SIADH
- ectopic production of ADH (any CNS or small cell lung pathology)
- Drug induced: SSRi, carbamazepine
- lesions in pathway of the baroreceptor system
73
Sectioning of pituitary stalk
triphasic response:
1. DI,
2. followed by SIADH,
3. followed by a return of DI
74
Pathophysiology of SIADH
- increased water retention, hyponatremia, but clinically euvolumic
1. Vol expansion increases ANP, decreases renin creating a natriuresis, which contributes to the nyponatremia
2. inappropriate [urine] can be greater than plasma osmolarity
- any urine Osm greater than 100 w hyponatremia is SIADH
